Centre de Recherche du CHUM
Montreal, Quebec, Canada
Research institute in Montreal, Quebec
900 Saint Denis St, Montreal, Quebec H2X 0A9
About Centre de Recherche du CHUM
"Le Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) est le plus grand centre de recherche en sciences biomédicales et soins de santé de l’Université de Montréal, et parmi les plus imposants au Canada."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Centre hospitalier de l'Université de Montréal (CHUM)
12
Gilead Sciences
6
Janssen Research & Development, LLC
4
Intercept Pharmaceuticals
3
Allena Pharmaceuticals
2
Boehringer Ingelheim
2
Canadian Network for Observational Drug Effect Studies, CNODES
2
Cytokinetics
2
PTC Therapeutics
2
Pfizer
2
Takeda
2
Clinical Trials at Centre de Recherche du CHUM
During the past decade, Centre de Recherche du CHUM conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 7 clinical trials were completed, i.e. on
average, 14.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 5 clinical trials were completed. i.e. 26.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
2007-10-01
2010-12-01
Completed
165
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
2008-01-17
2017-09-25
Completed
60
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa
2008-05-01
2009-08-01
Completed
160
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
2009-02-01
2012-12-01
Completed
153
Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
Approved for marketing
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG
2009-12-01
2016-06-01
Completed
20
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers
2010-01-01
2023-06-01
Active, not recruiting
2,253
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
2010-11-01
2011-04-01
Terminated
7
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centre de Recherche du CHUM" #1 sponsor was "Centre hospitalier de l'Université de Montréal (CHUM)" with 12 trials, followed by "Gilead Sciences" with 6 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Intercept Pharmaceuticals" with 3 trials sponsored and "Allena Pharmaceuticals"
with 3 trials sponsored. Other sponsors include 26 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche du CHUM"
#1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "Centre de Recherche du Centre Hospitalier de l'Université de Montréal" with 3 trials as a collaborator, "Drug Safety and Effectiveness Network, Canada" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Alberta Prion Research Institute" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 38 trials.
Clinical Trials Conditions at Centre de Recherche du CHUM
According to Clinical.Site data, the most researched conditions in "Centre de Recherche du CHUM" are
"Amyotrophic Lateral Sclerosis" (3 trials), "Heart Failure" (3 trials), "All-cause Mortality" (2 trials), "Atrial Fibrillation" (2 trials) and "Cystic Fibrosis" (2 trials). Many other conditions were trialed in "Centre de Recherche du CHUM" in a lesser frequency.
Clinical Trials Intervention Types at Centre de Recherche du CHUM
Most popular intervention types in "Centre de Recherche du CHUM" are "Drug" (41 trials), "Other" (7 trials), "Procedure" (5 trials), "Device" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "BI 685509" (2 trials), "Cetrelimab 480 mg" (2 trials), "PF-05221304" (2 trials) and "Reldesemtiv" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centre de Recherche du CHUM
The vast majority of trials in "Centre de Recherche du CHUM" are
50 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at Centre de Recherche du CHUM
Currently, there are 26 active trials in "Centre de Recherche du CHUM".
1 are not yet recruiting,
13 are recruiting,
11 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 22 completed trials in Centre de Recherche du CHUM,
1 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Centre de Recherche du CHUM, 4 "Phase 1"
clinical trials were conducted, 22 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 12 trials that are defined as “Not Applicable".